These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20394700)

  • 21. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in high LDL cholesterol, cholesterol-lowering medication use, and dietary saturated-fat intake: United States, 1976-2010.
    Kuklina EV; Carroll MD; Shaw KM; Hirsch R
    NCHS Data Brief; 2013 Mar; (117):1-8. PubMed ID: 23759124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and control of hypercholesterolaemia as defined by NCEP-ATPIII guidelines and predictors of LDL-C goal attainment in a multi-ethnic Asian population.
    Khoo CM; Tan ML; Wu Y; Wai DC; Subramaniam T; Tai ES; Lee J
    Ann Acad Med Singap; 2013 Aug; 42(8):379-87. PubMed ID: 24045373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
    Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
    Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.
    Ho KT; Chin KW; Ng KS; Alemao E; Rajagopalan S; Yin D
    Am J Cardiovasc Drugs; 2006; 6(6):383-91. PubMed ID: 17192128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 27. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.
    Raal F; Schamroth C; Blom D; Marx J; Rajput M; Haus M; Hussain R; Cassim F; Nortjé M; Vandehoven G; Temmerman AM
    Cardiovasc J Afr; 2011; 22(5):234-40. PubMed ID: 21922121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of prevalence, awareness, treatment and control of high LDL-C in Turkey.
    Sözmen K; Ünal B; Sakarya S; Dinç G; Yardım N; Keskinkılıç B; Ergör G
    Anatol J Cardiol; 2016 Jun; 16(6):370-84. PubMed ID: 27282671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Ballantyne CM; Shah S; Kher U; Hunter JA; Gill GG; Cressman MD; Ashraf TB; Johnson-Levonas AO; Mitchel YB
    Am J Cardiol; 2017 Feb; 119(3):388-396. PubMed ID: 27956003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.
    Barham AH; Goff DC; Chen H; Balasubramanyam A; Rosenberger E; Bonds DE; Bertoni AG
    Prev Cardiol; 2009; 12(2):95-101. PubMed ID: 19476583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Wong ND; Lopez V; Tang S; Williams GR
    Am J Cardiol; 2006 Jul; 98(2):204-8. PubMed ID: 16828593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and management of hypercholesterolemia in France, the Esteban observational study.
    Blacher J; Gabet A; Vallée A; Ferrières J; Bruckert E; Farnier M; Olié V
    Medicine (Baltimore); 2020 Dec; 99(50):e23445. PubMed ID: 33327276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population.
    Fedder DO; Koro CE; L'Italien GJ
    Circulation; 2002 Jan; 105(2):152-6. PubMed ID: 11790693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.